Editor's letter

Welcome to the latest issue of Pharmaceutical Technology Focus magazine

With increasing accesibility to artificial intelligence (AI) tools in daily life, patients can now obtain a greater depth of information about their condition, tailored to their individual needs. This issue’s cover story explores how using these AI applications will be vital in advancing medicine and healthcare, but human interaction might remain a vital part of patient care.

Also in this issue, we report on how Horizon EU funding could aid British biotech, and if a voucher system may incentivise antimicrobial drug discovery in Europe. Following several recent developments in the world of drugs for non-alcoholic steatohepatitis (NASH), we also have an article mapping the path forward for several investigational therapies.

Don’t miss the special thematic supplement replete with data and commentary on the potential for the pharma and healthcare sector in the metaverse. All this, with the latest news, analysis and data on the pharmaceutical and biotech industry.

Manasi Vaidya, editor